World News: 13:00 GMT Thursday 30th May 2019. [Gritstone Oncology, Inc via Globe Newswire via SPi World News]
EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it will webcast an event with key opinion leaders who will present on neoantigen-based immunotherapy on Monday, June 3, 2019 from 6:30-8:00 a.m. CT in Chicago.
A live audio webcast will be available within the Investors & Media section of the Gritstone Oncology website at . An archived replay will be accessible for 30 days following the event.
Investors: Alexandra Santos Wheelhouse Life Science Advisors (510) 871-6161
Globe Newswire: 13:00 GMT Thursday 30th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.